Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy
- 1 December 1993
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (12), 1111-1114
- https://doi.org/10.1111/j.1471-0528.1993.tb15175.x
Abstract
Measurement of alpha-fetoprotein (AFP) was used to investigate the occurrence of feto-maternal haemorrhage in women undergoing medical abortion. Three groups of women with amenorrhoea of 56 or less days were studied. A control and a mifepristone group had two blood samples taken 48 h apart. Women undergoing medical abortion with gemeprost had two blood samples taken 24 h apart. Medical Termination Unit, Simpson Memorial Maternity Pavilion, Edinburgh. Three hundred and thirty-five women requesting abortion. Blood samples taken at 24 h or 48 h apart. The rise in concentration of AFP in plasma was much higher (P = 0.01) in the two groups of women in whom abortion was induced by gemeprost or mifepristone than in control women. Whereas only 5% of women in the control group had a significant rise in AFP, 27% and 33% of women in the mifepristone and gemeprost groups, respectively, had a rise in AFP level which exceeded the 95th centile (> or = 38%). The concentration of hCG rose by 48 h in both control and mifepristone groups. Progesterone remained unchanged, and oestradiol decreased (P < 0.02) in the mifepristone group. By 24 h, there was a significant fall in the concentrations of hCG, progesterone and oestradiol in the group who had aborted after being given gemeprost. Anti-D prophylaxis must be administered to rhesus negative women to avoid rhesus iso-immunisation.Keywords
This publication has 15 references indexed in Scilit:
- Medical abortion in women of ≤56 days amenorrhoea; a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprostBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristoneFertility and Sterility, 1991
- Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Reduced risk of isoimmunisation in medical abortionThe Lancet, 1990
- The incidence of fetomaternal haemorrhage following elective termination of first-trimester pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1988
- Elevation of maternal α–fetoprotein serum levels in relation to fetomaternal haemorrhage after second trimester pregnancy termination by aspirotomyBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- DOES CHORIONIC VILLUS SAMPLING CAUSE FETOMATERNAL HAEMORRHAGE?The Lancet, 1985
- DETECTION OF FETOMATERNAL HÆMORRHAGE BY MEASUREMENT OF MATERNAL SERUM-ALPHA-FETOPROTEINThe Lancet, 1976
- ALPHA‐FETOPROTEIN LEVELS IN MATERNAL PLASMA AND AMNIOTIC FLUID DURING PROSTAGLANDIN‐INDUCED MID‐TRIMESTER ABORTIONS: THE RELATION TO FETAL DISTRESS AND DEATHBJOG: An International Journal of Obstetrics and Gynaecology, 1976